PlainPill

CBD vs CBG for anxiety

Short answer: For anxiety, more users report improvement with CBG — 100% of 5 reports, versus 88% of 185 for CBD.

CBD has 286 meta-analyses and 344 randomized trials on PubMed; CBG has 28 and 77.

Based on 482 reports about CBD and 25 about CBG. Not medical advice.

CBD
Supplement
CBG
Substance
Users say it helped59%helped236 reports · high confidence64%helped11 reports · few reports
Verdict
Mixed
Mostly positive
ResearchAResearch: StrongAResearch: Strong
Meta-analyses / RCTs286 / 34428 / 77
Mainly used for
Anxiety
% reporting improvement
88% (185)100% (5)
Sleep
% reporting improvement
72% (76)50% (2)
Mood
% reporting improvement
85% (34)67% (3)
Pain & inflammation
% reporting improvement
80% (35)—
Focus
% reporting improvement
83% (12)50% (4)
Common side effectsbrain fog, headache, wakefulness, subdued feelinginsomnia, stimulation
Typical dose reported30-60 mg; 54 mg / after dinner; before bed10 mg
CBD
Latest review conclusion

In addition, this meta-analysis focuses on the efficacy of CBD in treating anxiety disorders such as generalized anxiety disorder (GAD), social anxiety disorder (SAD), and post-traumatic stress disorder (PTSD). However, caution should be exercised in interpreting our findings due to the limited size of the clinical sample, and additional trials ought to be carried out if deemed necessary.

Psychiatry Res, 2024 ↗
What a user said
“I take it for sleeping and anxiety and it works so well, even after five years. I haven't build up any tolerance.”
Full CBD profile →
CBG
Latest review conclusion

Compared with warfarin, DOACs have more favorable efficacy and safety profiles among patients with atrial fibrillation.

Circulation, 2022 ↗
What a user said
“cbg specifically gives me some really nice effects helps me think outside the box a little, usually really good for verbal fluency”
Full CBG profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate